News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,207 Results
Type
Article (88178)
Company Profile (825)
Press Release (784183)
Multimedia
Podcasts (206)
Webinars (31)
Section
Business (233347)
Career Advice (4152)
Deals (39895)
Drug Delivery (156)
Drug Development (91477)
Employer Resources (205)
FDA (18436)
Job Trends (17440)
News (398124)
Policy (39996)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (164)
Alliances (56982)
ALS (191)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (377)
Approvals (18636)
Artificial intelligence (678)
Autoimmune disease (192)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (694)
Cancer (5326)
Cardiovascular disease (472)
Career advice (3578)
Career pathing (43)
CAR-T (318)
CDC (68)
Celiac Disease (2)
Cell therapy (873)
Cervical cancer (39)
Clinical research (77393)
Collaboration (1942)
Company closure (5)
Compensation (1226)
Complete response letters (79)
COVID-19 (3003)
CRISPR (107)
C-suite (962)
Cystic fibrosis (156)
Data (6667)
Decentralized trials (2)
Denatured (76)
Depression (161)
Diabetes (554)
Diagnostics (7321)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100713)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135811)
Executive appointments (1069)
FDA (21799)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1636)
Gene editing (230)
Generative AI (71)
Gene therapy (715)
GLP-1 (1168)
Government (5482)
Grass and pollen (8)
Guidances (389)
Healthcare (20979)
HIV (76)
Huntington's disease (53)
IgA nephropathy (90)
Immunology and inflammation (310)
Immuno-oncology (75)
Indications (133)
Infectious disease (3320)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17971)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (663)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (716)
Lymphoma (396)
Machine learning (48)
Management (66)
Manufacturing (920)
MASH (182)
Medical device (15089)
Medtech (15154)
Mergers & acquisitions (23042)
Metabolic disorders (1476)
mRNA (201)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (384)
Neuropsychiatric disorders (108)
Neuroscience (3244)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5121)
Now hiring (70)
Obesity (722)
Opinion (348)
Ovarian cancer (175)
Pain (226)
Pancreatic cancer (251)
Parkinson's disease (317)
Partnered (39)
Patents (546)
Patient recruitment (548)
Peanut (65)
People (67147)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23910)
Phase 2 (33580)
Phase 3 (25307)
Pipeline (6036)
Policy (358)
Postmarket research (3554)
Preclinical (10722)
Press Release (72)
Prostate cancer (272)
Psychedelics (60)
Radiopharmaceuticals (318)
Rare diseases (1008)
Real estate (7445)
Recruiting (81)
Regulatory (29343)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (275)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1192)
Venture capital (101)
Weight loss (495)
Women's health (104)
Worklife (23)
Date
Today (179)
Last 7 days (954)
Last 30 days (3082)
Last 365 days (32835)
2026 (5520)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (51689)
Australia (9083)
California (12177)
Canada (3468)
China (1230)
Colorado (514)
Connecticut (528)
Delaware (362)
Europe (118930)
Florida (1812)
Georgia (395)
Hawaii (4)
Idaho (68)
Illinois (1014)
India (80)
Indiana (574)
Iowa (24)
Japan (466)
Kansas (135)
Kentucky (47)
Louisiana (33)
Maine (84)
Maryland (1514)
Massachusetts (8923)
Michigan (380)
Minnesota (685)
Mississippi (7)
Missouri (145)
Montana (36)
Nebraska (30)
Nevada (133)
New Hampshire (88)
New Jersey (3271)
New Mexico (33)
New York (3204)
North Carolina (1680)
North Dakota (10)
Northern California (5891)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2421)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4714)
Tennessee (185)
Texas (1912)
United States (43786)
Utah (369)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1009)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 873,207 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
How North Carolina Attracted Amgen and Roche To Become a Next-Gen Obesity Drug Production Hotspot
Infrastructure and location have helped make Holly Springs a future hub for obesity drug production, with Amgen and Roche planning to manufacture GLP-1 therapies there to compete in the growing market.
March 3, 2026
·
4 min read
·
Nick Paul Taylor
Press Releases
Election of employee representatives to the Board of Directors of Novo Nordisk A/S
March 3, 2026
·
2 min read
Press Releases
LRS SECURES IDE TO STUDY ITS THERMOSUIT COOLING DEVICE IN A PIVOTAL TRIAL OF ISCHEMIC STROKE PATIENTS
March 3, 2026
·
2 min read
Opinion
Navigating the FDA After the Storm To Advance Drug Candidates
Here’s how drug developers can best approach interactions with the agency following last year’s seismic changes to its leadership, workforce and policies.
March 3, 2026
·
4 min read
·
John Kirk
FDA
FDA’s Circle of Trust Is Shrinking, Making Many Decisions Feel Like ‘Fiat’
FDA decisions lack majority consensus, experts agree, possibly leading to less nuanced verdicts on new drug applications. This type of “fiat” decisionmaking, as multiple regulatory experts have called it, is also bleeding into the agency’s policymaking.
March 3, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
March 2, 2026
·
2 min read
Press Releases
ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy
March 2, 2026
·
4 min read
Press Releases
Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair®
March 2, 2026
·
3 min read
Press Releases
Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results
March 2, 2026
·
4 min read
Press Releases
Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress
March 2, 2026
·
4 min read
1 of 87,321
Next
